GlassScriptPhysician profile
Zalmai Afzali
NPI 1407177397
$2,108.58
in general payments reported to CMS, 2019-2025
29 companies · $337 in 2025
The $337 reported for 2025 was more than what 85% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $190 · 2021: $137 · 2022: $295 · 2023: $478 · 2024: $362 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,177.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $341.71 | 2022-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $334.60 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $182.92 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $157.37 | 2020-2024 | Andexxa, Farxiga |
| Paratek Pharmaceuticals, INC. | $133.26 | 2023-2024 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $120.81 | 2019-2023 | |
| Gilead Sciences, INC. | $77.16 | 2022-2024 | Veklury |
| Baxter Healthcare | $75.47 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.89 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $61.86 | 2019-2021 | |
| Vifor Pharma, INC. | $61.34 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $42.66 | 2023 | |
| Ferring Pharmaceuticals INC. | $39.77 | 2022 | |
| Pfizer INC. | $36.34 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $35.81 | 2023 | Xarelto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35.20 | 2019-2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.67 | 2023 | Spevigo |
| Ionis Pharmaceuticals, INC. | $32.70 | 2025 | Tryngolza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.38 | 2024 | Caplyta |
| Stryker Corporation | $27.81 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $24.44 | 2025 | |
| Astellas Pharma US INC | $23.45 | 2023 | Cresemba |
| Exact Sciences Corporation | $23.13 | 2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $22.29 | 2025 | Gvoke Hypopen |
| Electromed, INC. | $19.80 | 2024 | Smartvest |
| Edwards Lifesciences Corporation | $19.40 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Vertex Pharmaceuticals Incorporated | $17.70 | 2025 | |
| Abbott Laboratories | $17.62 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $13.02 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zalmai Afzali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.